Family Care Hospitals Ltd Stock Price Today (NSE: FAMILYCARE)
Fundamental Score
Family Care Hospitals Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Family Care Hospitals Ltd share price today is ₹2.89, up +0.00% on NSE/BSE as of 18 March 2026. Family Care Hospitals Ltd (FAMILYCARE) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹20.69 (Cr). The 52-week high for FAMILYCARE share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of 85.52% and a debt-to-equity ratio of 0.59.
Family Care Hospitals Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Family Care Hospitals Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Family Care Hospitals Share Price: An Analysis of ROCE Efficiency
One critical, often overlooked, dynamic in the Healthcare Service Provider sector is the direct correlation between operational efficiency and patient trust. A leaner, more profitable operation can often reinvest more effectively in patient care and technology. This analysis examines the financial performance of Family Care Hospitals Ltd, focusing particularly on its impressive Return on Capital Employed (ROCE). Currently, the Family Care Hospitals share price stands at ₹3.55, with a reported ROCE of 79.25%. However, the company’s Price-to-Earnings (PE) ratio is currently unavailable, making a direct valuation comparison challenging.
The exceptionally high ROCE of 79.25% suggests that Family Care Hospitals is highly efficient in utilizing its capital to generate profits. This metric indicates a strong ability to convert investments into earnings. This level of profitability can be viewed as a significant economic moat, enabling the company to potentially reinvest in growth initiatives, acquire smaller competitors, or even weather industry downturns more effectively. The strength of a company's economic moat is a critical factor in long-term investment considerations.
While ROCE offers valuable insight, it's essential to contextualize it within the peer group. Comparing Family Care Hospitals Ltd with peers such as
Suraksha Diagnostic Ltd becomes crucial. For example, a detailed examination of management quality and its impact on operational efficiency at Suraksha Diagnostic Ltd, alongside a review of their respective financial statements, can highlight areas where Family Care Hospitals excels or faces potential vulnerabilities. Such a comparative analysis is vital for a comprehensive understanding of relative performance. A deeper dive into the asset turnover and profit margins underpinning the ROCE would provide further granularity.It's important to note that a high ROCE, while positive, should be validated across multiple financial periods and accounting standards to ensure its sustainability. Furthermore, without a PE ratio, assessing the market's current valuation of the company relative to its earnings potential is not possible. This analysis is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra, and provides an observational view based on publicly available data. It should not be interpreted as financial advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Family Care Hospitals Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of FAMILYCARE across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Return on Equity (85.52%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (79.25%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (36.71%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Excellent EPS Growth (203.86% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (186.18% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Risk Factors
9 factors identified
Profit Decline Concern (-114.70%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-98.20%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-9.83% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-20.03x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-19.19 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (18.54%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Limited Institutional Interest (FII+DII: 0.09%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
High Share Pledging Risk (61.71%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Family Care Hospitals Ltd Financial Statements
Comprehensive financial data for Family Care Hospitals Ltd including income statement, balance sheet and cash flow
About FAMILYCARE (Family Care Hospitals Ltd)
Family Care Hospitals Ltd (FAMILYCARE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Service Provider sector with a current market capitalisation of ₹20.69 (Cr). Family Care Hospitals Ltd has delivered a Return on Equity (ROE) of 85.52% and a ROCE of 79.25%. The debt-to-equity ratio stands at 0.59, reflecting the company's capital structure. Investors tracking FAMILYCARE share price can monitor key metrics including P/E ratio, promoter holding of 18.54%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
Latest News
FAMILYCARE Share Price: Frequently Asked Questions
What is the current share price of Family Care Hospitals Ltd (FAMILYCARE)?
As of 18 Mar 2026, 10:14 am IST, Family Care Hospitals Ltd share price is ₹2.89. The FAMILYCARE stock has a market capitalisation of ₹20.69 (Cr) on NSE/BSE.
Is FAMILYCARE share price Overvalued or Undervalued?
FAMILYCARE share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 39.28x. Based on this relative valuation, the Family Care Hospitals Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of FAMILYCARE share price?
The 52-week high of FAMILYCARE share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Family Care Hospitals Ltd share price?
Key factors influencing FAMILYCARE share price include quarterly earnings growth (Sales Growth: -98.20%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Family Care Hospitals Ltd a good stock for long-term investment?
Family Care Hospitals Ltd shows a 5-year Profit Growth of 186.18% and an ROE of 85.52%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.59 before investing in FAMILYCARE shares.
How does Family Care Hospitals Ltd compare with its industry peers?
Family Care Hospitals Ltd competes with major peers in the Healthcare Service Provider. Investors should compare FAMILYCARE share price P/E of 0.00x and ROE of 85.52% against the industry averages to determine competitive standing.
What is the P/E ratio of FAMILYCARE and what does it mean?
FAMILYCARE share price has a P/E ratio of N/Ax compared to the industry average of 39.28x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is FAMILYCARE performing according to Bull Run's analysis?
FAMILYCARE has a Bull Run fundamental score of 7/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does FAMILYCARE belong to?
FAMILYCARE operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Family Care Hospitals Ltd share price.
What is Return on Equity (ROE) and why is it important for FAMILYCARE?
FAMILYCARE has an ROE of 85.52%, which indicates excellent management efficiency. ROE measures how efficiently Family Care Hospitals Ltd generates profits from shareholders capital.
How is FAMILYCARE debt-to-equity ratio and what does it indicate?
FAMILYCARE has a debt-to-equity ratio of 0.59, which indicates moderate leverage that should be monitored.
What is FAMILYCARE dividend yield and is it a good dividend stock?
FAMILYCARE offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Family Care Hospitals Ltd shares.
How has FAMILYCARE share price grown over the past 5 years?
FAMILYCARE has achieved 5-year growth rates of: Sales Growth -9.83%, Profit Growth 186.18%, and EPS Growth 203.86%.
What is the promoter holding in FAMILYCARE and why does it matter?
Promoters hold 18.54% of FAMILYCARE shares, with 61.71% pledged. High promoter holding often indicates strong management confidence in Family Care Hospitals Ltd.
What is FAMILYCARE market capitalisation category?
FAMILYCARE has a market capitalisation of ₹21 crores, placing it in the Small-cap category.
How volatile is FAMILYCARE stock?
FAMILYCARE has a beta of N/A. A beta > 1 suggests the Family Care Hospitals Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is FAMILYCARE operating profit margin trend?
FAMILYCARE has a 5-year average Operating Profit Margin (OPM) of 36.71%, indicating the company's operational efficiency.
How is FAMILYCARE quarterly performance?
Recent quarterly performance shows Family Care Hospitals Ltd YoY Sales Growth of -98.20% and YoY Profit Growth of -114.70%.
What is the institutional holding pattern in FAMILYCARE?
FAMILYCARE has FII holding of 0.00% and DII holding of 0.09%. Significant institutional holding often suggests professional confidence in the Family Care Hospitals Ltd stock.